https://ribopro.us/news/ribopro-introduces-new-company-logo/ 2022-11-14T22:21:19+00:00 https://ribopro.us/news/ceo-co-founder-ribopro-elected-most-promising-entrepreneur-of-the-year/ 2022-11-14T22:21:45+00:00 https://ribopro.us/news/ribopro-wins-blue-tulip-award/ 2022-11-14T22:22:33+00:00 https://ribopro.us/news/ribopro-officially-1-year/ 2022-11-14T22:23:23+00:00 https://ribopro.us/news/ribopro-raises-e1-2m-to-become-leader-in-mrna/ 2022-11-14T22:24:00+00:00 https://ribopro.us/news/ribopro-joins-the-wellcome-leap-health-breakthrough-network/ 2023-02-16T10:49:04+00:00 https://ribopro.us/news/ardena-and-ribopro-forge-strategic-alliance-to-support-the-rna-revolution-with-end-to-end-manufacturing-of-advanced-mrna-and-lnp-solutions/ 2023-07-05T12:30:43+00:00 https://ribopro.us/news/biotech-scale-up-ribopro-announces-funding-round-to-support-preclinical-development-and-international-expansion/ 2023-07-21T07:33:01+00:00 https://ribopro.us/news/ribopro-secures-series-a-funding-to-accelerate-mrna-based-technologies/ 2025-01-02T10:58:55+00:00 https://ribopro.us/news/ribopro-and-ipa-partner-to-advance-mrna-driven-antibody-discovery-unlocking-new-frontiers-in-immunotherapy/ 2025-02-26T13:30:55+00:00 https://ribopro.us/news/ribopro-cla-2024q1/ 2025-10-23T14:48:45+00:00 https://ribopro.us/news/ribopro-selected-for-pharmanl-shared-development-infrastructure-2025-call/ 2026-03-03T12:41:11+00:00